Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care

Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care

Several studies have suggested the potential role of Magnesium Sulfate (MgSO<sub>4</sub>) for the treatment of Atrial Fibrillation (AF) but, in clinical practice, the use of magnesium is not standardized although it is largely used for the treatment of supraventricular arrhythmias. Objec...

Full description

Bibliographic Details
Main Authors: Emanuele Gilardi, Fulvio Pomero, Enrico Ravera, Andrea Piccioni, Michele Cosimo Santoro, Nicola Bonadia, Annamaria Carnicelli, Luca Di Maurizio, Luca Sabia, Yaroslava Longhitano, Angela Saviano, Veronica Ojetti, Gabriele Savioli, Christian Zanza, Francesco Franceschi
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
atrial fibrillation
magnesium sulfate
Flecainide
rhythm control
rate control
Online Access:https://www.mdpi.com/2077-0383/11/19/5527

Internet

https://www.mdpi.com/2077-0383/11/19/5527

Similar Items